SEBIA

SEBIA is a global in vitro diagnostics company specializing in capillary electrophoresis and protein analysis systems for clinical laboratories. The company manufactures and distributes a comprehensive portfolio of automated instruments, reagent assays, and software solutions for the diagnosis and monitoring of chronic and metabolic diseases, including multiple myeloma, hemoglobinopathies, autoimmune disorders, genetic diseases, and infectious diseases. SEBIA's product range includes standalone and integrated workcell configurations of electrophoresis instruments (such as the Capillaris 3 TERA system) paired with corresponding serum, urine, and specialized protein electrophoresis tests. The company operates in over 120 countries with approximately 20,000 installed instruments worldwide and employs over 1,300 staff. SEBIA offers complementary services including data analysis and interpretation software, Sebia Lean Service (laboratory management and optimization), Sebia Academy (scientific training and education), and Sebia Service (technical and scientific customer support). The company positions itself as providing solutions that translate patient biomarkers into clinically actionable diagnostic information, supporting laboratory efficiency and patient outcomes in clinical chemistry and immunology.